Lorazepam
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names:Almazine, Alzapam, Anxiedin, Aplacassee, Ativan, Bonatranquan, Delormetazepam, Emotival, Idalprem, Lorabenz, Lorax, Loraz, Lorazepam Intensol, Lorsilan, Pro Dorm, Psicopax, Punktyl, Quait, Securit, Sedatival, Sedazin, Somagerol, Tavor, Temesta, Wypax
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Dosing and Administration
Ativan (lorazepam) is administered orally. For optimal results, dose, frequency of
administration, and duration of therapy should be individualized according to
patient response.
The usual range is 2 to 6 mg/day given in divided doses, the largest dose being
taken before bedtime, but the daily dosage may vary from 1 to 10 mg/day.
For anxiety, most patients require an initial dose of 2 to 3 mg/day given b.i.d. or
t.i.d.
For insomnia due to anxiety or transient situational stress, a single daily dose of
2 to 4 mg may be given, usually at bedtime.
For elderly or debilitated patients, an initial dosage of 1 to 2 mg/day in divided
doses is recommended, to be adjusted as needed and tolerated.
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Lorazepam
Return to top
Publication Resources
Most Recent Articles on Lorazepam
Review Articles on Lorazepam
Articles on Lorazepam in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Lorazepam
Return to top
Trial Resources
Ongoing Trials with Lorazepam at Clinical Trials.gov
Trial Results with Lorazepam
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Lorazepam
Cochrane Collaboration on Lorazepam
Cost Effectiveness of Lorazepam
Return to top
Media Resources
Powerpoint Slides on Lorazepam
Images of Lorazepam
Podcasts & MP3s on Lorazepam
Videos on Lorazepam
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Lorazepam
Discussion Groups on Lorazepam
Patient Handouts on Lorazepam
Blogs on Lorazepam
Lorazepam in the News
Lorazepam in the Marketplace
Return to top
International Resources
Lorazepam en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.

